Willingness to Participate in Longitudinal Research Among People with Chronic Pain Who Take Medical Cannabis: A Cross-Sectional Survey

被引:5
作者
Bachhuber, Marcus A. [1 ]
Arnsten, Julia H. [1 ]
Starrels, Joanna L. [1 ]
Cunningham, Chinazo O. [1 ]
机构
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Gen Internal Med, 3300 Kossuth Ave, Bronx, NY 10467 USA
基金
美国国家卫生研究院;
关键词
medical marijuana; marijuana; chronic pain; cohort studies; analgesics; OBTAINING INFORMED CONSENT; CLINICAL-TRIALS; UNITED-STATES; PRESCRIPTION OPIOIDS; MARIJUANA LAWS; ATTITUDES; CANCER; SUBSTITUTE; BARRIERS; OPINIONS;
D O I
10.1089/can.2017.0051
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Regulatory barriers limit clinical trials of medical cannabis in the United States. Longitudinal cohort studies may be one feasible alternative that could yield clinically relevant information. Willingness to participate in such studies is not known. Materials and Methods: In October 2016, we surveyed a convenience sample of patients with chronic pain from two New York registered organizations (responsible for growing, processing, distributing, and retailing medical cannabis products). After a vignette describing a longitudinal cohort study involving weekly patient-reported outcomes and quarterly assessments of physical functioning and urine and blood tests, we asked about respondents' willingness to participate. We examined willingness to participate, duration of participation, and frequency of data collections overall and by subgroups, using multivariable logistic regression models. Results: Of 405 respondents (estimated response rate: 30%), 54% were women and 81% were white non-Hispanic. Neuropathy was the most common pain condition (67%) followed by inflammatory bowel disease (19%). Of respondents, 94% (95% CI 92-97%) thought that the study should be done, 85% (95% CI 81-88%) would definitely or probably enroll if asked, 76% (95% CI 72-81%) would participate for >= 1 year, and 59% (95% CI 54-64%) would respond to questions at least daily. Older age was the only factor associated with lower willingness to participate, lower willingness to participate for >= 1 year, and lower willingness to respond to questions at least daily. Conclusions: Nearly all respondents were supportive of the proposed study and most reported that they would enroll if asked. Enhanced engagement with older individuals may be needed to promote equal enrollment. Recruitment for longitudinal cohort studies with frequent data collection appears feasible in this patient population.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 63 条
  • [1] Cannabis in painful HIV-associated sensory neuropathy - A randomized placebo-controlled trial
    Abrams, D. I.
    Jay, C. A.
    Shade, S. B.
    Vizoso, H.
    Reda, H.
    Press, S.
    Kelly, M. E.
    Rowbotham, M. C.
    Petersen, K. L.
    [J]. NEUROLOGY, 2007, 68 (07) : 515 - 521
  • [2] [Anonymous], 2016, DEA ANNOUNCES ACTION
  • [3] Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
    Bachhuber, Marcus A.
    Saloner, Brendan
    Cunningham, Chinazo O.
    Barry, Colleen L.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1668 - 1673
  • [4] Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain
    Boehnke, Kevin F.
    Litinas, Evangelos
    Clauw, Daniel J.
    [J]. JOURNAL OF PAIN, 2016, 17 (06) : 739 - 744
  • [5] Medical Marijuana Laws May Be Associated With A Decline In The Number Of Prescriptions For Medicaid Enrollees
    Bradford, Ashley C.
    Bradford, W. David
    [J]. HEALTH AFFAIRS, 2017, 36 (05) : 945 - 951
  • [6] Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
    Bradford, Ashley C.
    Bradford, W. David
    [J]. HEALTH AFFAIRS, 2016, 35 (07) : 1230 - 1236
  • [7] Exploring the lived experience of adults using prescription opioids to manage chronic noncancer pain
    Brooks, Erica A.
    Unruh, Anita
    Lynch, Mary E.
    [J]. PAIN RESEARCH & MANAGEMENT, 2015, 20 (01) : 15 - 22
  • [8] Participation in Cancer Clinical Trials: Why Are Patients Not Participating?
    Byrne, Margaret M.
    Tannenbaum, Stacey L.
    Gluck, Stefan
    Hurley, Judith
    Antoni, Michael
    [J]. MEDICAL DECISION MAKING, 2014, 34 (01) : 116 - 126
  • [9] Obtaining informed consent for cancer pain research: Do patients with advanced cancer and patients with chronic pain have different concerns?
    Casarett, D
    Karlawish, J
    Sankar, P
    Hirschman, KB
    Asch, DA
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 24 (05) : 506 - 516
  • [10] Designing pain research from the patient's perspective: What trial end points are important to patients with chronic pain?
    Casarett, D
    Karlawish, J
    Sankar, P
    Hirschmann, K
    Asch, DA
    [J]. PAIN MEDICINE, 2001, 2 (04) : 309 - 316